XTLB
XTL Biopharmaceuticals
XTLB
XTLB
4 hedge funds and large institutions have $262K invested in XTL Biopharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$3K |
Top Sellers
| 1 |
1
Ameriprise
Minneapolis,
Minnesota
|
$0 |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$2K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Invesco
Atlanta,
Georgia
| $257K | 129,811 | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $3K | 1,574 | +1,574 | New |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $2K | 1,026 | -123 | -11% |
|
|
4
Ameriprise
Minneapolis,
Minnesota
| – | – | -441 | Closed |
|
5
Morgan Stanley
New York
| $0 | 4 | – | – |
|